Acebutolol hydrochloride and Weakness - a phase IV clinical study of FDA data

Summary:

Weakness is reported as a side effect among people who take Acebutolol hydrochloride (acebutolol hydrochloride), especially for people who are male, 60+ old, also take Calcium, and have Crohn's disease.

The phase IV clinical study analyzes which people have Weakness when taking Acebutolol hydrochloride. It is created by eHealthMe based on reports of 1,566 people who have side effects when taking Acebutolol hydrochloride from the FDA, and is updated regularly.

What is Acebutolol hydrochloride?

Acebutolol hydrochloride has active ingredients of acebutolol hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 1,635 Acebutolol hydrochloride users. Check the latest studies of Acebutolol hydrochloride.

What is Weakness?

Weakness is found to be associated with 3,640 drugs and 6,612 conditions by eHealthMe. Check the latest studies of Weakness.

On Jul, 14, 2026

1,566 people reported to have side effects when taking Acebutolol hydrochloride.
Among them, 36 people (2.3%) have Weakness.

Could Acebutolol hydrochloride cause Weakness?

Among these 36 people:

What is the gender of people who have Weakness when taking Acebutolol hydrochloride? *

female: 41.38 %
male: 58.62 %

What is the age of people who have Weakness when taking Acebutolol hydrochloride? *

What are other drugs people take besides Acebutolol hydrochloride? *

What are other side effects people have besides Weakness? *

Fall: 16 people, 44.44%
Weight Decreased: 13 people, 36.11%
Body Temperature Decreased: 12 people, 33.33%
Fatigue (feeling of tiredness): 11 people, 30.56%
Urinary Tract Infection: 11 people, 30.56%
Heart Rate Decreased: 11 people, 30.56%
Dizziness: 10 people, 27.78%
Headache (pain in head): 10 people, 27.78%
Joint Pain: 9 people, 25.00%
Gastroenteritis (inflammation of stomach and intestine): 8 people, 22.22%

What are the existing conditions these people have? *

Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 14 people, 38.89%
Pain: 7 people, 19.44%
Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 4 people, 11.11%
Diabetes: 3 people, 8.33%
Dyslipidaemia (abnormal amount of lipids): 2 people, 5.56%
Chronic Kidney Disease: 2 people, 5.56%
Lung Carcinoma Cell Type Unspecified Stage Iv (the lung cancer has spread to other organs of the body, such as the other lung, brain, or liver): 2 people, 5.56%
Back Pain: 2 people, 5.56%
Cerebral Ischaemia (insufficient blood flow to the brain to meet metabolic demand): 2 people, 5.56%
Squamous Cell Carcinoma (a cancer of a kind of epithelial cell): 2 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Acebutolol hydrochloride and have Weakness?

- Check whether Weakness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Acebutolol hydrochloride:

Acebutolol hydrochloride (1,635 reports)

Weakness treatments and more:

Weakness (586,876 reports)

Browse all side effects of Acebutolol hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weakness:

Weakness (3,640 drugs)

Browse all the conditions that are associated with Weakness:

Weakness (6,612 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on acebutolol hydrochloride (the active ingredients of Acebutolol hydrochloride) and Acebutolol hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.